XTLB News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$4.6M

Volume

1.50K

Next Earnings

N/A

Chart Earnings News About Insider Filings

Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future PaymentsBeyond Air Inc. (NASDAQ:XAIR) has agreed to sell 85% of its subsidiary NeuroNOS Ltd. to XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) in exchange for 19.9% equity stake in XTL, $1 million cash, and up to $32.5 million in milestone-based payments. NeuroNOS, which focuses on autism therapeutics and holds FDA Orphan Drug Designations, will become XTL's flagship platform. Beyond Air shares surged 163.70% on the announcement.Benzinga · Jan 13, 2026

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific LeadershipXTL Biopharmaceuticals announced a binding agreement to acquire 85% of NeuroNOS Ltd., a subsidiary of Beyond Air, Inc., positioning itself as a major player in autism therapeutics. The acquisition includes two Nobel Laureates in Chemistry and autism researcher Prof. Haitham Amal. NeuroNOS has secured FDA Orphan Drug Designations for Phelan-McDermid Syndrome and Glioblastoma. XTL will pay 19.9% of its share capital, $1 million cash, and up to $32.5 million in milestone payments.Benzinga · Jan 13, 2026

XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.comXTL Biopharmaceuticals, an Israeli pharmaceutical company, announced the results of its Annual and Extraordinary General Meeting, including the re-election of board members and the appointment of independent auditors. The company also confirmed the acquisition of The Social Proxy Ltd., which will add two new directors to its board.Investing.com · Jul 22, 2024

XTL Entered Definitive Agreement to Acquire The Social Proxyexpands its IP portfolio to AI Web DataGlobeNewswire Inc. · Jun 5, 2024

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day SessionShares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) and Landos Biopharma, reported a definitive agreement under which AbbVie will acquire Landos. Landos Biopharma shares jumped 171.2% to $21.70 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Next.e.GO N.V. (NASDAQ: EGOX) shares jumped 85.8% to $0.0730 after falling around 22% on Friday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) shares climbed 70.1% to $2.9255 after the company announced a collaboration with Univercells Group on nanoparticle-delivered mRNA vaccines. MicroAlgo Inc. (NASDAQ: MLGO) climbed 34.3% to $5.40 after declining around 5% on Friday. XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) gained 32.4% to $3.4690. XTL Biopharmaceuticals recently entered into a binding term sheet to acquire all of the issued and outstanding share capital of Social Proxy. Nkarta, Inc. (NASDAQ: NKTX) gained 23.3% to $11.00 after the company priced $240 million underwritten offering. Target Hospitality Corp. (NASDAQ: TH) jumped 21.3% to $10.82 after the company received a buyout offer from TDR Capital. Swvl Holdings Corp. (NASDAQ: SWVL) rose 21.2% to $11.26. Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) surged 21% to $0.6949. Lucid Group, Inc. (NASDAQ: LCID) jumped 18.7% to $3.29 after the company announced a $1 billion investment by an affiliate of PIF. Sagimet Biosciences Inc. (NASDAQ: SGMT) rose 16.9% to $5.27 after the company reported FY results and announced the appointment of Tim Walbert and Paul Hoelscher to its Board of Director. Ocugen, Inc. (NASDAQ: OCGN) jumped 16.4% to $1.9101. The Third Circuit Court of Appeals recently upheld the decision of the Eastern District of Pennsylvania to dismiss with prejudice the consolidated securities class action lawsuits against Ocugen. Flora Growth Corp. (NASDAQ: FLGC) shares gained 15.2% to $1.8206 after surging around 34% on Friday. Forge Global Holdings, Inc. (NYSE: FRGE) shares gained 14.5% to $2.67 after ...Benzinga · Mar 25, 2024

Dow Surges 350 Points; Fed Holds Rates SteadyU.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also rose, gaining, 0.78% to 5,218.70. Check This Out: Exxon Mobil, Palantir Technologies And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Consumer discretionary shares rose by 1.3% on Wednesday. In trading on Wednesday, health care shares fell by 0.4%. Top Headline The Federal Reserve kept interest rates unchanged Wednesday between 5.25% and 5.5% at its March meeting, as widely expected by investors, confirming intentions to lower the cost of money in the coming months. Equities Trading UP ETAO International Co., Ltd. (NASDAQ: ETAO) shares shot up 87% to $0.2670. The company announced a reverse stock split. Shares of XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) got a boost, surging 90% to $1.96 after the company announced plans to acquire The Social Proxy. TruGolf Holdings, Inc. ...Benzinga · Mar 20, 2024

Crude Oil Dips 2%; Signet Jewelers Shares Spike HigherU.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% to 16,165.15. The S&P 500 also rose, gaining, 0.01% to 5,178.79. Check This Out: Exxon Mobil, Palantir Technologies And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Industrials shares rose by 0.5% on Wednesday. In trading on Wednesday, energy shares fell by 0.6%. Top Headline Crude oil inventories in the U.S. declined by 1.952 million barrels in the week ended March 15, versus market estimates of a 0.013 million gain. Equities Trading UP ETAO International Co., Ltd. (NASDAQ: ETAO) shares shot up 80% to $0.2581. The company announced a reverse stock split. Shares of XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) got a boost, surging 113% to $2.19 after the company announced plans to acquire The Social Proxy. TruGolf Holdings, Inc. ...Benzinga · Mar 20, 2024

US Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top ViewsU.S. stocks traded slightly lower this morning, ahead of interest-rate decision from the Federal Reserve. Following the market opening Wednesday, the Dow traded down 0.01% to 39,106.88 while the NASDAQ fell 0.06% to 16,157.27. The S&P 500 also fell, dropping, 0.02% to 5,177.26. Check This Out: Exxon Mobil, Palantir Technologies And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Utilities shares rose by 0.5% on Wednesday. In trading on Wednesday, energy shares fell by 0.5%. Top Headline General Mills, Inc. (NYSE: GIS) reported better-than-expected fourth-quarter financial results. General Mills reported a third-quarter FY24 sales decline of 1% year-on-year to $5.099 billion, beating the analyst consensus estimate of $4.962 billion. Adjusted EPS of $1.17 beat the analyst consensus estimate of $1.05. Equities Trading UP ETAO International Co., Ltd. (NASDAQ: ETAO) shares shot up 106% to $0.2950. The company announced a reverse stock split. Shares of XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) got a boost, surging 78% to ...Benzinga · Mar 20, 2024

XTL To Aquire The Social Proxyexpands its IP portfolio to AI Web DataGlobeNewswire Inc. · Mar 20, 2024

XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelRamat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets consists of an IP portfolio relating to hCDR1 for the treatment of systemic lupus erythematosus, or SLE, and Sjögren’s syndrome, or SS, today addressed the status of the Company's continued and uninterrupted activity in Israel against the background of the recent severe terrorist attack in the south of the country and the subsequent declaration of war by the Israeli government against the Hamas terrorist organization.GlobeNewswire Inc. · Oct 20, 2023

XTLBXTL Biopharmaceuticals Ltd. American Depositary Shares

XTLB

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any XTLB yet.

Related Tickers

Earnings

Volume

1.50K